Champions Oncology
CSBR
CSBR
37 hedge funds and large institutions have $100M invested in Champions Oncology in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
12.36% more ownership
Funds ownership: 39.08% → 51.44% (+12%)
Holders
37
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.14M | |
| 2 | +$2.89M | |
| 3 | +$2.77M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.18M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.16M |
Top Sellers
| 1 | -$444K | |
| 2 | -$411K | |
| 3 | -$76K | |
| 4 |
SSB
Sandy Spring Bank
Olney,
Maryland
|
-$53K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$17.5K |